Recent Progress in Gene Therapy and Other Targeted Therapeutic Approaches for Beta Thalassemia

Current Drug Targets
Eman M HamedRaghda R S Hussein

Abstract

Beta-thalassemia is a genetic disorder characterized by the impaired synthesis of the betaglobin chain of adult hemoglobin. The disorder has a complex pathophysiology that affects multiple organ systems. The main complications of beta thalassemia are ineffective erythropoiesis, chronic hemolytic anemia and hemosiderosis-induced organ dysfunction. Regular blood transfusions are the main therapy for beta thalassemia major; however, this treatment can cause cardiac and hepatic hemosiderosis - the most common cause of death in these patients. This review focuses on unique future therapeutic interventions for thalassemia that reverse splenomegaly, reduce transfusion frequency, decrease iron toxicity in organs, and correct chronic anemia. The targeted effective protocols include hemoglobin fetal inducers, ineffective erythropoiesis correctors, antioxidants, vitamins, and natural products. Resveratrol is a new herbal therapeutic approach which serves as fetal Hb inducer in beta thalassemia. Hematopoietic stem cell transplantation (HSCT) is the only curative therapy for beta thalassemia major and is preferred over iron chelation and blood transfusion for ensuring long life in these patients. Meanwhile, several molecular therapies, such...Continue Reading

References

Jan 4, 1979·The New England Journal of Medicine·P A de AlarconJ A Stockman
Nov 30, 2000·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·B AldudakN Dikmen
Mar 23, 2004·Acta Haematologica·Amal El-BeshlawyAli Taher
Feb 18, 2005·European Journal of Pediatrics·Vasileios Tsagris, Georgia Liapi-Adamidou
Mar 29, 2005·The Oncologist·Edvardas KaminskasRichard Pazdur
Oct 13, 2006·Annals of Hematology·Amal El-BeshlawyAli Taher
Jun 17, 2008·The American Journal of Pathology·Francesca VinchiEmanuela Tolosano
Apr 28, 2009·Transplantation·Giovanni StalloneLoreto Gesualdo
Jul 20, 2010·Advances in Medical Sciences·Y Z Xue, L X Wang
Aug 18, 2010·Annals of the New York Academy of Sciences·Eitan Fibach, Eliezer A Rachmilewitz
May 4, 2012·Journal of the Academy of Nutrition and Dietetics·Ellen B FungUNKNOWN Thalassemia Clinical Research Network
Nov 16, 2012·Blood Cells, Molecules & Diseases·Ashutosh LalElliott Vichinsky
Jan 11, 2013·Pediatric Hematology and Oncology·Galila M MokhtarHeba T A Ali
Jul 31, 2013·Transfusion·Elliott VichinskyUNKNOWN CDC Thalassemia Investigators
Feb 21, 2014·Trends in Pharmacological Sciences·Piotr Ruchala, Elizabeta Nemeth
Jul 30, 2014·Hematology/oncology Clinics of North America·Maria Marsella, Caterina Borgna-Pignatti
Dec 31, 2014·Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion·Rachna KheraA P Dubey
Jul 23, 2015·Journal of Pediatric Hematology/oncology·Venée N TubmanUNKNOWN Thalassemia Clinical Research Network
Nov 1, 2015·Clinical Therapeutics·Caterina Borgna-Pignatti, Maria Marsella
Jan 30, 2016·Annals of the New York Academy of Sciences·Ellen B Fung
Apr 14, 2016·Blood Cells, Molecules & Diseases·Andria TheodorouMarina Kleanthous
Jul 23, 2016·Frontiers in Pharmacology·Giada SebastianiKostas Pantopoulos
Jul 30, 2016·Journal of the Academy of Nutrition and Dietetics·Eleese Cunningham
Nov 17, 2016·Best Practice & Research. Clinical Obstetrics & Gynaecology·Chi-Kong Li
Nov 22, 2016·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Daniel Vyoral, Jiri Petrak
Nov 27, 2016·Best Practice & Research. Clinical Obstetrics & Gynaecology·Irena Hudecova, Rossa W K Chiu
Jan 26, 2017·Molecular and Cellular Endocrinology·Olivier SalaminNicolas Leuenberger
Apr 28, 2017·Expert Review of Hematology·Ami Belmont, Janet L Kwiatkowski

❮ Previous
Next ❯

Citations

Jul 19, 2021·Archives of Virology·Sepideh NasimzadehFateme Jahangiri Mehr

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

© 2021 Meta ULC. All rights reserved